Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

The GH/IGF-1 axis in ageing and longevity

Møller, N & Jørgensen, J. O. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–177 (2009). Article CAS PubMed Google Scholar Zadik, Z., Chalew, S. A., McCarter, R. J. Jr, Meistas, M. & Kowarski, A. A. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 60, 513–516 (1985). Article CAS PubMed Google Scholar Bartke, A. Growth hormone and aging: a challenging controversy. Clin. Interv. Aging 3, 659–665 (2008). Article CAS PubMed PubMed Central Google Scholar Rudman, D. et al. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323, 1–6 (1990). Article CAS PubMed Google Scholar Liu, H. et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Intern. Med. 146, 104–115 (2007). Article PubMed Google Scholar Fontana, L., Partridge, L. & Longo, V. D. Extending healthy life span—from yeast to humans.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Møller, N & Jørgensen, J. O. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–177 (2009).

Article CAS PubMed Google Scholar

Zadik, Z., Chalew, S. A., McCarter, R. J. Jr, Meistas, M. & Kowarski, A. A. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 60, 513–516 (1985).

Article CAS PubMed Google Scholar

Bartke, A. Growth hormone and aging: a challenging controversy. Clin. Interv. Aging 3, 659–665 (2008).

Article CAS PubMed PubMed Central Google Scholar

Rudman, D. et al. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323, 1–6 (1990).

Article CAS PubMed Google Scholar

Liu, H. et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Intern. Med. 146, 104–115 (2007).

Article PubMed Google Scholar

Fontana, L., Partridge, L. & Longo, V. D. Extending healthy life span—from yeast to humans. Science 328, 321–326 (2010).

Article CAS PubMed PubMed Central Google Scholar

Snell, G. D. Dwarf, a new Mendelian recessive character of the house mouse. Proc. Natl Acad. Sci. USA 15, 733–734 (1929).

Article CAS PubMed PubMed Central Google Scholar

Eicher, E. M. & Beamer, W. G. New mouse dw allele: genetic location and effects on lifespan and growth hormone levels. J. Hered. 71, 187–190 (1980).

Article CAS PubMed Google Scholar

Li, S. et al. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347, 528–533 (1990).

Article CAS PubMed Google Scholar

Flurkey, K., Papaconstantinou, J., Miller, R. A. & Harrison, D. E. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl Acad. Sci. USA 98, 6736–6741 (2001).

Article CAS PubMed PubMed Central Google Scholar

Brooks, N. L. et al. Low utilization of circulating glucose after food withdrawal in Snell dwarf mice. J. Biol. Chem. 282, 35069–35077 (2007).

Article CAS PubMed Google Scholar

Vergara, M., Smith-Wheelock, M., Harper, J. M., Sigler, R. & Miller, R. A. Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant. J. Gerontol. A. Biol. Sci. Med. Sci. 59, 1244–1250 (2004).

Article PubMed Google Scholar

Schaible, R. & Gowen, J. W. A new dwarf mouse. Genetics 46, 896 (1961).

Google Scholar

Buckwalter, M. S., Katz, R. W. & Camper, S. A. Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross. Genomics 10, 515–526 (1991).

Article CAS PubMed Google Scholar

Andersen, B. et al. The Ames dwarf gene is required for Pit-1 gene activation. Dev. Biol. 172, 495–503 (1995).

Article CAS PubMed Google Scholar

Sornson, M. W. et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327–333 (1996).

Article CAS PubMed Google Scholar

Brown-Borg, H. M., Borg, K. E., Meliska, C. J. & Bartke, A. Dwarf mice and the ageing process. Nature 384, 33 (1996).

Article CAS PubMed Google Scholar

Bartke, A. et al. Extending the lifespan of long-lived mice. Nature 414, 412 (2001).

Article CAS PubMed Google Scholar

Panici, J. A. et al. Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB J. 24, 5073–5079 (2010).

Article CAS PubMed PubMed Central Google Scholar

Krzisnik, C., Grgurić, S. Cvijović, K. & Laron, Z. Longevity of the hypopituitary patients from the island Krk: a follow-up study. Pediatr. Endocrinol. Rev. 7, 357–362 (2010).

PubMed Google Scholar

Krzisnik, C. et al. The “little people” of the island of Krk—revisited. Etiology of hypopituitarism revealed. J. Endocr. Genet. 1, 9–19 (1999).

Google Scholar

Eicher, E. M. & Beamer, W. G. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. J. Hered. 67, 87–91 (1976).

Article CAS PubMed Google Scholar

Godfrey, P. et al. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat. Genet. 4, 227–232 (1993).

Article CAS PubMed Google Scholar

Donahue, L. R. & Beamer, W. G. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 136, 91–104 (1993).

Article CAS PubMed Google Scholar

Salvatori, R. et al. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84, 917–923 (1999).

CAS PubMed Google Scholar

Aguiar-Oliveira, M. H. et al. Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 95, 714–721 (2010).

Article CAS PubMed Google Scholar

Baumann, G. & Maheshwari, H. The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. Acta Paediatr. Suppl. 423, 33–38 (1997).

Article CAS PubMed Google Scholar

Maheshwari, H. G., Silverman, B. L., Dupuis, J. & Baumann, G. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: dwarfism of Sindh. J. Clin. Endocrinol. Metab. 83, 4065–4074 (1998).

CAS PubMed Google Scholar

Besson, A. et al. Reduced longevity in untreated patients with isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 88, 3664–3667 (2003).

Article CAS PubMed Google Scholar

Dobbs, A. K. et al. Cutting edge: a hypomorphic mutation in Igβ (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J. Immunol. 179, 2055–2059 (2007).

Article CAS PubMed Google Scholar

Zhou, Y. et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl Acad. Sci. USA 94, 13215–13220 (1997).

Article CAS PubMed PubMed Central Google Scholar

Laron, Z. & Kopchick, J. (Eds) Laron Syndrome—From Man to Mouse (Springer, 2011).

Book Google Scholar

List, E. O. et al. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR−/−) mouse. Endocr. Rev. 32, 356–386 (2011).

Article CAS PubMed Google Scholar

Coschigano, K. T., Clemmons, D., Bellush, L. L. & Kopchick, J. J. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141, 2608–2613 (2000).

Article CAS PubMed Google Scholar

Coschigano, K. T. et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin and IGF-1 levels and increased lifespan. Endocrinology 144, 3799–3810 (2003).

Article CAS PubMed Google Scholar

Berryman, D. E. et al. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm. IGF Res. 14, 309–318 (2004).

Article CAS PubMed Google Scholar

Berryman, D. E. et al. Two-year body composition analyses of long-lived GHR null mice. J. Gerontol. A. Biol. Sci. Med. Sci. 65, 31–40 (2010).

Article CAS PubMed Google Scholar

Methuselah Foundation. Latest Mprize Winners [online], (2013)

Bonkowski, M. S., Rocha, J. S., Masternak, M. M., Al Regaiey, K. A. & Bartke, A. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc. Natl Acad. Sci. USA 103, 7901–7905 (2006).

Article CAS PubMed PubMed Central Google Scholar

Laron, Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958–2003. J. Clin. Endocrinol. Metab. 89, 1031–1044 (2004).

Article CAS PubMed Google Scholar

Laron, Z., Avitzur, Y. & Klinger, B. Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism 44 (Suppl. 4), 113–118 (1995).

Article CAS PubMed Google Scholar

Laron, Z. The GH–IGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones (Athens) 7, 24–27 (2008).

Article Google Scholar

Rosenbloom, A. L., Guevara Aguirre, J., Rosenfeld, R. G. & Fielder, P. J. The little women of Loja—growth hormone-receptor deficiency in an inbred population of southern Ecuador. N. Engl. J. Med. 323, 1367–1374 (1990).

Article CAS PubMed Google Scholar

Guevara-Aguirre, J. et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3, 70ra13 (2011).

Article CAS PubMed PubMed Central Google Scholar

Steuerman, R., Shevah, O. & Laron, Z. Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur. J. Endocrinol. 164, 485–489 (2011).

Article CAS PubMed Google Scholar

Chen, W. Y., Wight, D. C., Mehta, B. V., Wagner, T. E. & Kopchick, J. J. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol. Endocrinol. 5, 1845–1852 (1991).

Article CAS PubMed Google Scholar

Chen, W. Y., White, M. E., Wagner, T. E. & Kopchick, J. J. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129, 1402–1408 (1991).

Article CAS PubMed Google Scholar

Palmiter, R. D. et al. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300, 611–615 (1982).

Article CAS PubMed PubMed Central Google Scholar

Palmer, A. J. et al. Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150, 1353–1360 (2009).

Article CAS PubMed Google Scholar

Bartke, A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78, 210–216 (2003).

Article CAS PubMed Google Scholar

Quaife, C. J. et al. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124, 40–48 (1989).

Article CAS PubMed Google Scholar

Chanson, P. & Salenave, S. Acromegaly. Orphanet J. Rare Dis. 3, 17, (2008).

Article PubMed PubMed Central Google Scholar

Eugster, E. A. & Pescovitz, O. H. Gigantism. J. Clin. Endocrinol. Metab. 84, 4379–4384 (1999).

Article CAS PubMed Google Scholar

Katznelson, L. Alterations in body composition in acromegaly. Pituitary 12, 136–142 (2008).

Article CAS Google Scholar

Ayuk, J. & Sheppard, M. C. Does acromegaly enhance mortality? Rev. Endocr. Metab. Disord. 9, 33–39 (2008).

Article PubMed Google Scholar

Melmed, S. Acromegaly pathogenesis and treatment. J. Clin. Invest. 119, 3189–3202 (2009).

Article CAS PubMed PubMed Central Google Scholar

Holdaway, I. M., Bolland, M. J. & Gamble, G. D. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159, 89–95 (2008).

Article CAS PubMed Google Scholar

Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J. & Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59–72 (1993).

CAS PubMed Google Scholar

Sjögren, K. et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl Acad. Sci. USA 96, 7088–7092 (1999).

Article PubMed PubMed Central Google Scholar

Yakar, S. et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl Acad. Sci. USA 96, 7324–7329, (1999).

Article CAS PubMed PubMed Central Google Scholar

Svensson, J. et al. Liver-derived IGF-I regulates mean life span in mice. PLoS ONE 6, e22640 (2011).

Article CAS PubMed PubMed Central Google Scholar

Novosyadlyy, R. & Leroith, D. Insulin-like growth factors and insulin: at the crossroad between tumor development and longevity. J. Gerontol. A. Biol. Sci. Med. Sci. 67, 640–651 (2012).

Article CAS PubMed Google Scholar

Li, Q., Ceylan-Isik, A. F., Li, J. & Ren, J. Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction. Rejuvenation Res. 11, 725–733 (2008).

Article CAS PubMed PubMed Central Google Scholar

Conover, C. A. et al. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131, 1187–1194 (2004).

Article CAS PubMed Google Scholar

Conover, C. A. & Bale, L. K. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 6, 727–729 (2007).

Article CAS PubMed Google Scholar

Conover, C. A. Key questions and answers about pregnancy-associated plasma protein-A. Trends Endocrinol. Metab. 23, 242–249 (2012).

Article CAS PubMed PubMed Central Google Scholar

Conover, C. A. et al. Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. J. Gerontol. A Biol. Sci. Med. Sci. 65, 590–599 (2010).

Article CAS PubMed Google Scholar

Holzenberger, M. et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182–187 (2003).

Article CAS PubMed Google Scholar

Bokov, A. F. et al. Does reduced IGF-1R signaling in Igf1r+/− mice alter aging? PLoS ONE 6, e26891 (2011).

Article CAS PubMed PubMed Central Google Scholar

Ladiges, W. et al. Lifespan extension in genetically modified mice. Aging Cell 8, 346–352 (2009).

Article CAS PubMed Google Scholar

Tazearslan, C., Huang, J., Barzilai, N. & Suh, Y. Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles. Aging Cell 10, 551–554 (2011).

Article CAS PubMed Google Scholar

Suh, Y. et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl Acad. Sci. USA 105, 3438–3442 (2008).

Article PubMed PubMed Central Google Scholar

Kurosu, H. et al. Suppression of aging in mice by the hormone Klotho. Science 309, 1829–1833 (2005).

Article CAS PubMed PubMed Central Google Scholar

Wolf, I. et al. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27, 7094–7105 (2008).

Article CAS PubMed Google Scholar

Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997).

Article CAS PubMed Google Scholar

Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998).

Article CAS PubMed Google Scholar

Previs, S. F., Withers, D. J., Ren, J. M., White, M. F. & Shulman, G. I. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275, 38990–38994 (2000).

Article CAS PubMed Google Scholar

Tamemoto, H. et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182–186 (1994).

Article CAS PubMed Google Scholar

Selman, C. et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22, 807–818 (2008).

Article CAS PubMed Google Scholar

Selman, C., Partridge, L. & Withers, D. J. Replication of extended lifespan phenotype in mice with deletion of insulin receptor substrate 1. PLoS ONE 6, e16144 (2011).

Article CAS PubMed PubMed Central Google Scholar

Taguchi, A., Wartschow, L. M. & White, M. F. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317, 369–372 (2007).

Article CAS PubMed Google Scholar

Selman, C., Lingard, S., Gems, D., Partridge, L. & Withers, D. J. Comment on “Brain IRS2 signaling coordinates life span and nutrient homeostasis”. Science 320, 1012 (2008).

Article CAS PubMed Google Scholar

Barbieri, M. et al. The IRS2 Gly1057Asp variant is associated with human longevity. J. Gerontol. A. Biol. Sci. Med. Sci. 65, 282–286 (2010).

Article CAS PubMed Google Scholar

Ranieri, S. C. et al. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proc. Natl Acad. Sci. USA 107, 13420–13425 (2010).

Article PubMed PubMed Central Google Scholar

Migliaccio, E. et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309–313 (1999).

Article CAS PubMed Google Scholar

Bartke, A. Healthy aging: is smaller better?—a mini-review. Gerontology 58, 337–343 (2012).

Article PubMed Google Scholar

Tran, T. T., Yamamoto, Y., Gesta, S. & Kahn, C. R. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 7, 410–420 (2008).

Article CAS PubMed PubMed Central Google Scholar

Kregel, K. C. & Zhang, H. J. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R18–R36 (2007).

Article CAS PubMed Google Scholar

Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232–236 (2011).

Article CAS PubMed PubMed Central Google Scholar

Haruna, Y. et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc. Natl Acad. Sci. USA 104, 2331–2336 (2007).

Article CAS PubMed PubMed Central Google Scholar

Harper, J. M., Durkee, S. J., Dysko, R. C., Austad, S. N. & Miller, R. A. Genetic modulation of hormone levels and life span in hybrids between laboratory and wild-derived mice. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 1019–1029 (2006).

Article PubMed Google Scholar

Murakami, S. Stress resistance in long-lived mouse models. Exp. Gerontol. 41, 1014–1019 (2006).

Article CAS PubMed Google Scholar

Fulda S., Gorman A. M., Hori O. & Samali A. Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010, 214074 (2010).

PubMed PubMed Central Google Scholar

Wullschleger S, Loewith R. & Hall M. N. TOR signaling in growth and metabolism. Cell 124, 471–484 (2006).

Article CAS PubMed Google Scholar

Zoncu R., Efeyan A. & Sabatini D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21–35 (2011).

Article CAS PubMed Google Scholar

Pérez, V. I. et al. Is the oxidative stress theory of aging dead? Biochim. Biophys. Acta 1790, 1005–1014 (2009).

Article CAS PubMed PubMed Central Google Scholar

Amador-Noguez, D. et al. Alterations in xenobiotic metabolism in the long-lived Little mice. Aging Cell 6, 453–470 (2007).

Article CAS PubMed Google Scholar

Chhabra, Y., Waters, M. J. & Brooks, A. J. Role of the growth hormone-IGF-1 axis in cancer. Expert Rev. Endocrinol. Metab. 6, 71–84 (2011).

Article CAS PubMed Google Scholar

Ikeno, Y., Bronson, R. T., Hubbard, G. B., Lee, S. & Bartke, A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J. Gerontol. A. Biol. Sci. Med. Sci. 58, 291–296 (2003).

Article PubMed Google Scholar

Majeed, N. et al. A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene 24, 4736–4740 (2005).

Article CAS PubMed Google Scholar

Ikeno, Y. et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J. Gerontol. A. Biol. Sci. Med. Sci. 64, 522–529 (2009).

Article CAS PubMed Google Scholar

Pollak, M., Blouin, M. J., Zhang, J. C. & Kopchick, J. J. Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist. Br. J. Cancer 85, 428–430 (2001).

Article CAS PubMed PubMed Central Google Scholar

Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).

Article CAS PubMed PubMed Central Google Scholar

Wang, M. & Miller, R. A. Augmented autophagy pathways and MTOR modulation in fibroblasts from long-lived mutant mice. Autophagy 8, (2012).

Thorner, M. O. Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span. J. Gerontol. A. Biol. Sci. Med. Sci. 64, 1039–1044 (2009).

Article CAS PubMed Google Scholar

Elbornsson M. et al. Fifteen years of growth hormone (GH) replacement improves body composition and cardiovascular risk factors. Eur. J. Endocrinol. http://dx.doi.org/10.1530/EJE-12-1083.

Blackman M. R. et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288, 2282–2292 (2002).

Article CAS PubMed Google Scholar

Vestergaard, P. et al. Local administration of growth hormone stimulates tendon collagen synthesis in elderly men. J. Appl. Physiol. 113, 1432–1438 (2012).

Article CAS PubMed Google Scholar

Trainer, P. J. ACROSTUDY: the first 5 years. Eur. J. Endocrinol. 161 (Suppl. 1), S19–S24 (2009).

Article CAS PubMed Google Scholar

van der Lely, A. J. et al. Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J. Clin. Endocrinol. Metab. 97, 1589–1597 (2012).

Article CAS PubMed Google Scholar

Parkinson C. et al. A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. J. Clin. Endocrinol. Metab. 4, 1797–1804 (2002).

Article Google Scholar

Liang, H. et al. Genetic mouse models of extended lifespan. Exp. Gerontol. 38, 1353–1364, (2003).

Article CAS PubMed Google Scholar

Yakar, S. et al. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50, 1110–1118 (2001).

Article CAS PubMed Google Scholar

McCay, C. M., Crowell, M. F. & Maynard, L. A. The effect of retarded growth upon the length of the life span and upon the ultimate body size. 1935. Nutrition 5, 155–171 (1989).

CAS PubMed Google Scholar

Katic M. & Kahn C. R. The role of insulin and IGF-1 signaling in longevity. Cell. Mol. Life Sci. 62, 320–343 (2005).

Article CAS PubMed Google Scholar

Omodei, D. & Fontana, L. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett. 585, 1537–1542 (2011).

Article CAS PubMed PubMed Central Google Scholar

Larson-Meyer, D. E. et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) 16, 1355–1362 (2008).

Article CAS Google Scholar

Heilbronn, L. K. et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295, 1539–1548 (2006).

Article CAS PubMed PubMed Central Google Scholar

Colman, R. J. et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201–204 (2009).

Article CAS PubMed PubMed Central Google Scholar

Mattison, J. A. et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 489, 318–321 (2012).

Article CAS PubMed Google Scholar

Connected topics

Follow this recovery question